ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 114 filers reported holding ALBIREO PHARMA INC in Q3 2020. The put-call ratio across all filers is 7.29 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $12,166 | -28.4% | 563 | -37.4% | 0.00% | – |
Q3 2022 | $17,000 | -98.6% | 900 | -98.5% | 0.00% | -100.0% |
Q2 2022 | $1,178,000 | +351.3% | 59,323 | +579.0% | 0.00% | – |
Q1 2022 | $261,000 | -78.5% | 8,737 | -83.3% | 0.00% | -100.0% |
Q4 2021 | $1,215,000 | +38.5% | 52,186 | +85.7% | 0.00% | 0.0% |
Q3 2021 | $877,000 | -46.3% | 28,099 | -39.5% | 0.00% | 0.0% |
Q2 2021 | $1,634,000 | -24.2% | 46,446 | -24.0% | 0.00% | 0.0% |
Q1 2021 | $2,155,000 | +1557.7% | 61,133 | +1669.9% | 0.00% | – |
Q4 2020 | $130,000 | +490.9% | 3,454 | +435.5% | 0.00% | – |
Q3 2020 | $22,000 | -54.2% | 645 | -64.1% | 0.00% | – |
Q2 2020 | $48,000 | -5.9% | 1,797 | -41.9% | 0.00% | – |
Q1 2020 | $51,000 | -7.3% | 3,093 | +41.8% | 0.00% | – |
Q4 2019 | $55,000 | +111.5% | 2,182 | +68.0% | 0.00% | – |
Q3 2019 | $26,000 | -72.3% | 1,299 | -55.1% | 0.00% | – |
Q2 2019 | $94,000 | +27.0% | 2,893 | +25.7% | 0.00% | – |
Q1 2019 | $74,000 | +23.3% | 2,302 | -5.6% | 0.00% | – |
Q4 2018 | $60,000 | -26.8% | 2,439 | -2.5% | 0.00% | – |
Q3 2018 | $82,000 | +34.4% | 2,502 | +46.5% | 0.00% | – |
Q2 2018 | $61,000 | – | 1,708 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 270,146 | $6,627,000 | 3.42% |
Perceptive Advisors | 1,704,330 | $39,506,000 | 1.50% |
Birchview Capital, LP | 38,000 | $932,000 | 0.88% |
SECTORAL ASSET MANAGEMENT INC | 229,978 | $5,641,000 | 0.77% |
BVF INC/IL | 200,500 | $4,918,000 | 0.64% |
Artal Group S.A. | 500,000 | $12,265,000 | 0.45% |
PA Capital LLC | 14,692 | $360,000 | 0.38% |
Chicago Capital, LLC | 180,911 | $4,438,000 | 0.36% |
TPG Group Holdings (SBS) Advisors, Inc. | 716,381 | $17,573,000 | 0.28% |
Fosun International Ltd | 197,005 | $4,492,000 | 0.27% |